I have a feeling it is both. That neither CYDY nor Amerex has conceded makes me believe that both feel it is in their best interest to sort it out, which to me confirms what was initially shared & merely raises eyebrows as to why LL is not an approved drug & lends to the finger-pointing.
Would be hard to convince an investor that this has been a blessing, but in my mind this/these trials & tribulations will serve to advance LL way beyond what any P-factor could have.